Danaparoid. A review of its pharmacology and clinical use in the management of heparin-induced thrombocytopenia.
Wilde, M I
Danaparoid. A review of its pharmacology and clinical use in the management of heparin-induced thrombocytopenia. [electronic resource] - Drugs Dec 1997 - 903-24 p. digital
Publication Type: Journal Article; Review
0012-6667
10.2165/00003495-199754060-00008 doi
Blood Coagulation--drug effects
Chondroitin Sulfates--adverse effects
Dermatan Sulfate--adverse effects
Drug Combinations
Heparin--adverse effects
Heparinoids--adverse effects
Heparitin Sulfate--adverse effects
Humans
Thrombocytopenia--chemically induced
Danaparoid. A review of its pharmacology and clinical use in the management of heparin-induced thrombocytopenia. [electronic resource] - Drugs Dec 1997 - 903-24 p. digital
Publication Type: Journal Article; Review
0012-6667
10.2165/00003495-199754060-00008 doi
Blood Coagulation--drug effects
Chondroitin Sulfates--adverse effects
Dermatan Sulfate--adverse effects
Drug Combinations
Heparin--adverse effects
Heparinoids--adverse effects
Heparitin Sulfate--adverse effects
Humans
Thrombocytopenia--chemically induced